S

Silfurberg

Europe, Gullbringusysla, Iceland, Reykjavík

Description

Silfurberg is an international venture capital firm that invests in early-stage health care, biotech, and other life science companies.

Investor Profile

Silfurberg has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series A rounds (top funding stages).
  • Majority of deals are located in Iceland.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series C (33%)
  • Series B (33%)
  • Series A (33%)

Country Focus

  • Iceland (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Silfurberg frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Innovation and Technology Venture Fund
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
Earlybird Venture Capital
Europe, Berlin, Germany, Berlin
Co-Investments: 1
BVCF
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Nan Fung Life Sciences
North America, California, United States, San Francisco
Co-Investments: 1
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 2
Tekla Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Brunnur Ventures
Europe, Gullbringusysla, Iceland, Reykjavík
Co-Investments: 3
Pivotal bioVenture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Hyfinity Investments
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Silfurberg?

Axelyf

Hafnarfjörður, Gullbringusysla, Iceland

Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.

BiotechnologyLife ScienceMedical
SeedAug 7, 2025
Amount Raised: $7,442,133
Oculis

Reykjavík, Gullbringusysla, Iceland

Oculis is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.

BiotechnologyHealth CarePharmaceutical
Series CMay 4, 2021
Amount Raised: $57,000,000
Oculis

Reykjavík, Gullbringusysla, Iceland

Oculis is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.

BiotechnologyHealth CarePharmaceutical
Series BJan 4, 2018
Amount Raised: $20,523,598
Oculis

Reykjavík, Gullbringusysla, Iceland

Oculis is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.

BiotechnologyHealth CarePharmaceutical
Series AAug 16, 2016

Find More Investors Like Silfurberg

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Silfurberg | Pipeseed